PT1355650E - Combinacao de ingredientes activos contendo alfuzosina e apomorfina - Google Patents

Combinacao de ingredientes activos contendo alfuzosina e apomorfina

Info

Publication number
PT1355650E
PT1355650E PT02711823T PT02711823T PT1355650E PT 1355650 E PT1355650 E PT 1355650E PT 02711823 T PT02711823 T PT 02711823T PT 02711823 T PT02711823 T PT 02711823T PT 1355650 E PT1355650 E PT 1355650E
Authority
PT
Portugal
Prior art keywords
apomorphine
active ingredients
combination
ingredients containing
alfuzosine
Prior art date
Application number
PT02711823T
Other languages
English (en)
Inventor
Arbilla Sonia
Ramirez Juan Fernando
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PT1355650E publication Critical patent/PT1355650E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
PT02711823T 2001-01-19 2002-01-18 Combinacao de ingredientes activos contendo alfuzosina e apomorfina PT1355650E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01400166A EP1224933A1 (en) 2001-01-19 2001-01-19 New combination of active ingredients containing alfuzosine and apomorphine

Publications (1)

Publication Number Publication Date
PT1355650E true PT1355650E (pt) 2006-05-31

Family

ID=8182601

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02711823T PT1355650E (pt) 2001-01-19 2002-01-18 Combinacao de ingredientes activos contendo alfuzosina e apomorfina

Country Status (10)

Country Link
US (1) US20040063736A1 (pt)
EP (2) EP1224933A1 (pt)
JP (1) JP2004517141A (pt)
AT (1) ATE314073T1 (pt)
DE (1) DE60208336T2 (pt)
DK (1) DK1355650T3 (pt)
ES (1) ES2254657T3 (pt)
PT (1) PT1355650E (pt)
SI (1) SI1355650T1 (pt)
WO (1) WO2002056887A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
DE69514794T2 (de) * 1994-04-22 2000-07-27 Pentech Pharmaceuticals Inc Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
EP1027054A4 (en) * 1997-10-28 2002-11-04 Vivus Inc LOCAL CONTRIBUTION OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION

Also Published As

Publication number Publication date
DK1355650T3 (da) 2006-05-15
JP2004517141A (ja) 2004-06-10
US20040063736A1 (en) 2004-04-01
EP1224933A1 (en) 2002-07-24
WO2002056887A1 (en) 2002-07-25
ATE314073T1 (de) 2006-01-15
SI1355650T1 (sl) 2006-06-30
ES2254657T3 (es) 2006-06-16
EP1355650B1 (en) 2005-12-28
DE60208336T2 (de) 2006-09-07
DE60208336D1 (de) 2006-02-02
EP1355650A1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
YU60903A (sh) Kompozicija i antivirusna aktivnost derivata supstituisanog azaindoloksoacetat piperazina
HUP0001089A2 (hu) Gyógyászati készítmények férfiak erekciós zavarainak kezelésére
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
MXPA04003796A (es) Tioacetamidas sustituidas.
GB0111186D0 (en) Novel compounds
BG105302A (en) Means for improving cognition
YU13301A (sh) Muskarinski agonisti i antagonisti
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
EA200400436A1 (ru) Медикаменты для профилактики и лечения бромидроза
HUP0400528A2 (hu) Neuropeptidáz Y inhibitor alkalmazása férfiak szexuális funkciózavarának kezelésére alkalmas gyógyszerkészítmény előállítására
PT1355650E (pt) Combinacao de ingredientes activos contendo alfuzosina e apomorfina
HUP0301915A2 (hu) Sildenafil és egyéb PDE5 inhibitor hatású vegyületek alkalmazása korai magömlés kezelésére szolgáló gyógyszerkészítmény elżállítására
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos
ATE333287T1 (de) Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten
SE0004780D0 (sv) Novel compunds
SE9902674D0 (sv) New composition
ATE386524T1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion